• Views: in the last
  • 13Week
  • 8Month
  • 118Total


  • NJ A2137
  • Requires health insurers to provide coverage for certain infant formulas.
Introduced
(1/27/2016)
In Committee
(10/6/2016)
Crossed OverPassedSignedDead/Failed/Vetoed
2016-2017 Regular Session
This bill amends P.L.2001, c.361 to clarify that all hospital, medical and health service corporations, individual, small employer and larger group insurers and health maintenance organizations shall provide coverage for expenses incurred in the purchase of specialized non-standard infant formulas, when the covered infant's physician has diagnosed the infant as having multiple food protein intolerance and has determined such formula to be medically necessary, and when the covered infant has not been responsive to trials of standard non-cow milk-based formulas, including soybean and goat milk. As originally enacted, P.L.2001, c.361 specified that insurers that provide coverage for prescription drugs shall provide the coverage for the infant formulas. This requirement has resulted in inequitable treatment of insured persons whose health benefits plans, which are subject to this law, do not include coverage for prescription drugs. Further, since some of the infant formulas covered under the law, such as Neocate, are not classified as prescription drugs, although they are administered under a physician's supervision, the insurance coverage for the infant formulas should not be limited to plans that only provide prescription drug coverage.
2nd Reading in the Assembly, Financial Institutions and Insurance
Reported out of Assembly Committee, 2nd Reading  (on 10/6/2016)
 
 

Date Chamber Action Description
10/6/2016 A Reported out of Assembly Committee, 2nd Reading
10/6/2016 Assembly Financial Institutions and Insurance Hearing (10:00 10/6/2016 Committee Room 16, Fourth Floor)
1/27/2016 A Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Date Motion Yea Nay Other
Detail 10/6/2016 Assembly Financial Institutions and Insurance Committee: Reported Favorably 11 0 2